OrbusNeich Medical Group Holdings (FRA:Q8T) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
OrbusNeich Medical Group Holdings EBITDA Margin % Related Terms
OrbusNeich Medical Group Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings EBITDA Margin % Chart
FRA:Q8T vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings (FRA:Q8T) has a EBITDA Margin % of 27.21% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 37% above median its historical median of 19.83. Over the past decade, OrbusNeich Medical Group Holdings' EBITDA Margin % has ranged from 7.13 to 35.07. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #114 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 14%.
Is OrbusNeich Medical Group Holdings' EBITDA Margin % too high?
OrbusNeich Medical Group Holdings' current EBITDA Margin % of 27.21% is 37% above median its 10-year median of 19.83. Over the past 10 years, this metric has ranged from a low of 7.13 to a high of 35.07. The Medical Devices & Instruments industry median EBITDA Margin % is 7.44. OrbusNeich Medical Group Holdings' value of 27.21% is 265.7% above this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #114 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #114 out of 817 companies for EBITDA Margin %. This places OrbusNeich Medical Group Holdings in the top 14% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.44. OrbusNeich Medical Group Holdings' value of 27.21% is 265.7% above this benchmark. Historically, OrbusNeich Medical Group Holdings' own EBITDA Margin % has ranged from 7.13 to 35.07 over the past decade. While the company's 10-year median is 19.83 vs. the industry median of 7.44, OrbusNeich Medical Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current EBITDA Margin % of 27.21% is 265.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current EBITDA Margin % is 27.21%, which is 37% above median its own 10-year median of 19.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current EBITDA Margin % of 27.21%. The stock's GF Value™ is €0.47, compared to a current price of €0.37 — trading 22.1% below its estimated fair value. The current EBITDA Margin % is 27.21%, which is 37% above median its 10-year median of 19.83 and 265.7% above the Medical Devices & Instruments industry median of 7.44. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current EBITDA Margin % is 27.21% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of €0.37 is trading 22.1% below its estimated GF Value™ of €0.47.
Key valuation signals for FRA:Q8T:
EBITDA Margin %: 27.21% (37% above median its 10-year median of 19.83)
GF Value™: €0.47 vs. price of €0.37 (22.1% below fair value)
Industry Position: 265.7% above the Medical Devices & Instruments median (#114 of 817)
No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score
Get the complete analysis for FRA:Q8T
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Q8T has been successfully added to your 
